Clinical predictors of calcification of xenoaortic biological prosthesis of valves
Abstract
A retrospective analysis of clinical status of the recipients of biological prosthesis in mitral position was conducted: group 1 included patients with histologically confirmed calcification, group 11 included patients with normal morphology andfunctioning ofprosthesis. Follow-up depth was 94,5 %, average terms are 8,0 ± 4,4 years, follow-up scope is2792 patient-years. More severe clinical condition and prolonged cardiopulmonary bypass time while conducting primary surgical interventions are specific for the patients of the 1 group. The risk factors of prosthesis calcification are degree of cardiac failure decompensation, duration and traumatizing effect of surgical intervention.
About the Author
O. K. Kuzmina
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Russian Federation
References
1. Барбараш Л.С., Барбараш Н.А., Журавлева И.Ю. Биопротезы клапанов сердца, проблемы и перспективы. - Кемерово, 1995. - 400 с
2. Bonow R., Carabello B., Chatterjee K. et al. ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons // J. Am. Coll. Cardiol. - 2006. - Vol. 48 (3). - P. e1-148
3. Grabenwoger M., Sider J., Fitzal F. et al. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material // Ann. Thorac. Surg. - 1996. - Vol. 62 (3). - P. 772-777.
4. Jamieson W.R., Cartier P.C., Allard M. et al. Surgical management of valvular heart disease // Can. J. Cardiol. - 2004. - Vol. 20, Suppl. E. - P. 7E-120E.
5. Oakley R., Kleine P., Bach D.S. Choice of prosthetic heart valve in today’s practice // Circulation. - 2008. - Vol. 117 (2). - P. 253-256.
6. Pibarot P., Dumesnil J. Prosthetic heart valves: selection of the optimal prosthesis and long-term management // Circulation. - 2009. - Vol. 119 (7). - P. 1034-1048.
7. Rahimtoola S.H. Choice of prosthetic heart valve for adult patients // J. Am. Coll. Cardiol. - 2003. - 41. - P. 893-904.
8. Ruel M., Kulik A., Rubens F.D. et al. Late incidence and determinants of reoperation in patients with prosthetic heart valves // Eur. J. Cardiothorac. Surg. - 2004. - Vol. 25. - P. 364-370.
9. Schoen F.J., Levy R.J. Calcification of tissue heart valve substitutes: progress toward understanding and prevention // Ann. Thorac. Surg. - 2005. - Vol. 79. - P. 1072-1080.
10. Sophie E.P., Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification // Circ. Res. - 2011. - Vol. 108. - P. 1381-1391.
11. Thiene G., Valente M. Anticalcification strategies to increase bioprosthetic valve durability // J. Heart Valve Dis. - 2011. - Vol. 20 (1). - P. 37-44.
12. Tillquist M., Maddox T. Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement // Patient Prefer Adherence. - 2011. - Vol. 5. - P. 91-99.
13. Van Geldorp M., Jamieson E., Kappetein A.P. et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk // J. Thorac. Cardiovasc. Surg. - 2009. - Vol. 137. - P. 881-886.
14. Vesey J.M., Otto C.M. Complication of prosthetic heart valves // Curr. Cardiol. Rep. - 2004. - Vol. 6. - P. 106-111.
Review
For citations:
Kuzmina O.K. Clinical predictors of calcification of xenoaortic biological prosthesis of valves. Acta Biomedica Scientifica. 2014;(5):17-19. (In Russ.)
Views:
315
Email this article 
